Yingqian Chen[Author] - Search Results

Year	Number of Results
2015	2
2016	3
2017	2
2018	1
2019	9
2020	7
2021	8
2022	7
2023	12
2024	6

1

Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy.

Wang L, Shao X, Zhong T, Wu Y, Xu A, Sun X, Gao H, Liu Y, Lan T, Tong Y, Tao X, Du W, Wang W, Chen Y, Li T, Meng X, Deng H, Yang B, He Q, Ying M, Rao Y. Wang L, et al. Among authors: chen y. Nat Chem Biol. 2021 May;17(5):567-575. doi: 10.1038/s41589-021-00742-5. Epub 2021 Mar 4. Nat Chem Biol. 2021. PMID: 33664520

2

Advances in differentiation therapy for osteosarcoma.

Chen Y, Cao J, Zhang N, Yang B, He Q, Shao X, Ying M. Chen Y, et al. Drug Discov Today. 2020 Mar;25(3):497-504. doi: 10.1016/j.drudis.2019.08.010. Epub 2019 Sep 6. Drug Discov Today. 2020. PMID: 31499188 Review.

3

Protein phase separation: A novel therapy for cancer?

Wang W, Chen Y, Xu A, Cai M, Cao J, Zhu H, Yang B, Shao X, Ying M, He Q. Wang W, et al. Among authors: chen y. Br J Pharmacol. 2020 Nov;177(22):5008-5030. doi: 10.1111/bph.15242. Epub 2020 Sep 28. Br J Pharmacol. 2020. PMID: 32851637 Free PMC article. Review.

4

Driving the degradation of oncofusion proteins for targeted cancer therapy.

Zhang X, Chen Y, Yang B, Shao X, Ying M. Zhang X, et al. Among authors: chen y. Drug Discov Today. 2023 Jun;28(6):103584. doi: 10.1016/j.drudis.2023.103584. Epub 2023 Apr 13. Drug Discov Today. 2023. PMID: 37061213 Review.

5

Altered large-scale individual-based morphological brain network in spinocerebellar ataxia type 3.

Su S, Sha R, Qiu H, Chu J, Lin L, Qian L, Hu M, Wu C, Cheung GL, Yang Z, Chen Y, Zhao J. Su S, et al. Among authors: chen y. CNS Neurosci Ther. 2023 Dec;29(12):4102-4112. doi: 10.1111/cns.14332. Epub 2023 Jun 30. CNS Neurosci Ther. 2023. PMID: 37392035 Free PMC article.

6

Advances in targeted therapy for osteosarcoma based on molecular classification.

Chen Y, Liu R, Wang W, Wang C, Zhang N, Shao X, He Q, Ying M. Chen Y, et al. Pharmacol Res. 2021 Jul;169:105684. doi: 10.1016/j.phrs.2021.105684. Epub 2021 May 19. Pharmacol Res. 2021. PMID: 34022396 Review.

7

Structural alterations of spinocerebellar ataxias type 3: from pre-symptomatic to symptomatic stage.

Qiu H, Wu C, Liang J, Hu M, Chen Y, Huang Z, Yang Z, Zhao J, Chu J. Qiu H, et al. Among authors: chen y. Eur Radiol. 2023 Apr;33(4):2881-2894. doi: 10.1007/s00330-022-09214-3. Epub 2022 Nov 12. Eur Radiol. 2023. PMID: 36370172

8

Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells.

Shao X, Chen Y, Wang W, Du W, Zhang X, Cai M, Bing S, Cao J, Xu X, Yang B, He Q, Ying M. Shao X, et al. Among authors: chen y. Acta Pharm Sin B. 2022 Apr;12(4):1856-1870. doi: 10.1016/j.apsb.2021.10.020. Epub 2021 Oct 23. Acta Pharm Sin B. 2022. PMID: 35847510 Free PMC article.

9

Assessment of the glymphatic function in children with attention-deficit/hyperactivity disorder.

Chen Y, Wang M, Su S, Dai Y, Zou M, Lin L, Qian L, Li X, Zhang H, Liu M, Chu J, Yang J, Yang Z. Chen Y, et al. Eur Radiol. 2024 Mar;34(3):1444-1452. doi: 10.1007/s00330-023-10220-2. Epub 2023 Sep 6. Eur Radiol. 2024. PMID: 37673963

10

Hybrid Electrolyte Design for High-Performance Zinc-Sulfur Battery.

Guo Y, Chua R, Chen Y, Cai Y, Tang EJJ, Lim JJN, Tran TH, Verma V, Wong MW, Srinivasan M. Guo Y, et al. Among authors: chen y. Small. 2023 Jul;19(29):e2207133. doi: 10.1002/smll.202207133. Epub 2023 Mar 27. Small. 2023. PMID: 36971296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year